Coming Soon

Definigen specializes in developing cutting-edge in vitro models of human aging and disease, utilizing induced pluripotent stem cells (iPSCs) to provide insights for research and therapeutic purposes.
Spinout Company
Public Funding Received
2019-05-01
Development of an optimised pancreatic cell tool kit to enable accelerated diabetes drug discovery
EU-Funded
2019-01-01
Platform for the development of optimised NAFLD liver cell models to accelerate drug development
Collaborative R&D
2016-01-01
3D culture model for Non-Alcoholic SteatoHepatitis (NASH) drug discovery
Collaborative R&D
2016-01-01
Development of a human 3D in vitro model of pancreatic beta cell health
Collaborative R&D